442 related articles for article (PubMed ID: 6334697)
1. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.
Wewers MD; Rennard SI; Hance AJ; Bitterman PB; Crystal RG
J Clin Invest; 1984 Dec; 74(6):2208-18. PubMed ID: 6334697
[TBL] [Abstract][Full Text] [Related]
2. Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay.
Wewers MD; Herzyk DJ
J Immunol; 1989 Sep; 143(5):1635-41. PubMed ID: 2788190
[TBL] [Abstract][Full Text] [Related]
3. Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide.
Bernaudin JF; Yamauchi K; Wewers MD; Tocci MJ; Ferrans VJ; Crystal RG
J Immunol; 1988 Jun; 140(11):3822-9. PubMed ID: 3259599
[TBL] [Abstract][Full Text] [Related]
4. Human alveolar macrophage and blood monocyte interleukin-6 production.
Kotloff RM; Little J; Elias JA
Am J Respir Cell Mol Biol; 1990 Nov; 3(5):497-505. PubMed ID: 2223104
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
Berkman N; John M; Roesems G; Jose PJ; Barnes PJ; Chung KF
J Immunol; 1995 Nov; 155(9):4412-8. PubMed ID: 7594602
[TBL] [Abstract][Full Text] [Related]
6. Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity.
Elias JA; Schreiber AD; Gustilo K; Chien P; Rossman MD; Lammie PJ; Daniele RP
J Immunol; 1985 Nov; 135(5):3198-204. PubMed ID: 3876379
[TBL] [Abstract][Full Text] [Related]
7. IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent.
Wewers MD; Dare HA; Winnard AV; Parker JM; Miller DK
J Immunol; 1997 Dec; 159(12):5964-72. PubMed ID: 9550394
[TBL] [Abstract][Full Text] [Related]
8. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
[TBL] [Abstract][Full Text] [Related]
9. Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity.
Friedlander MA; Hilbert CM; Wu YC; Finegan CK; Rich EA
J Lab Clin Med; 1994 Apr; 123(4):574-84. PubMed ID: 8145006
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
Hancock WW; Muller WA; Cotran RS
J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
[TBL] [Abstract][Full Text] [Related]
11. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
[TBL] [Abstract][Full Text] [Related]
12. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
Hunninghake GW
Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
[TBL] [Abstract][Full Text] [Related]
13. Impaired production and lack of secretion of interleukin 1 by human breast milk macrophages.
Subiza JL; Rodriguez C; Figueredo A; Mateos P; Alvarez R; de la Concha EG
Clin Exp Immunol; 1988 Mar; 71(3):493-6. PubMed ID: 3260159
[TBL] [Abstract][Full Text] [Related]
14. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.
Herzyk DJ; Allen JN; Marsh CB; Wewers MD
J Immunol; 1992 Nov; 149(9):3052-8. PubMed ID: 1401931
[TBL] [Abstract][Full Text] [Related]
15. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes.
Toossi Z; Hirsch CS; Hamilton BD; Knuth CK; Friedlander MA; Rich EA
J Immunol; 1996 May; 156(9):3461-8. PubMed ID: 8617974
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
[TBL] [Abstract][Full Text] [Related]
17. Human lung macrophages enhance and inhibit lymphocyte proliferation.
Liu MC; Proud D; Schleimer RP; Plaut M
J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
[TBL] [Abstract][Full Text] [Related]
18. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
Yoshimura T; Matsushima K; Oppenheim JJ; Leonard EJ
J Immunol; 1987 Aug; 139(3):788-93. PubMed ID: 3298433
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
